ABSORB STEMI: the TROFI II Study

Exclusion Criteria

• •1. Inability to provide informed consent;
• •2. Known pregnancy at time of randomization. Female who is breastfeeding at time of randomization;
• •3. Known intolerance to aspirin, heparin, PLLA (poly(L-lactic acid), everolimus, contrast material;
• •4. Cardiogenic Shock;
• •5. Unprotected left main coronary artery stenosis;
• •6. Distal occlusion of target vessel;
• •7. Acute myocardial infarction secondary to stent thrombosis;
• •8. Mechanical complications of acute myocardial infarction;
• •9. Severe tortuous, calcified or angulated coronary anatomy of the study vessel that in the opinion of the investigator would result in sub-optimal imaging or excessive risk of complication from placement of an OFDI catheter;
• •10. Fibrinolysis prior to PCI;
• •11. Active bleeding or coagulopathy or patients at chronic anticoagulation therapy;
• •12. Subject is currently participating in another clinical trial that has not yet completed its primary endpoint.